We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.
DBCLS will be closed for summer break from August 12 (Wed), 2026 - August 17 (Mon), 2026. After August 18 (Tue), we will respond to requests or questions which are received during this period. We sincerely apologize for any inconvenience this may cause and thank you for your kind understanding and cooperation.
Research list
397 results
Period
Experiment Overview
Subjects
Platform & Method
Sequencing Quality
Data Format
Policy
Click the cart icon next to the research ID or the JGAD dataset ID you want to apply for to add its datasets to your cart.
| Research ID | Datasets | Title | Category | Analysis method | Platforms | Participants | Access type | Data provider | Date published | Date modified | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| hum0343 | Development of COVID19 vaccine and evaluation system based on genetics of COVID-19 | Sequencing, Genome-wide association, Expression profiling | NGS (RNA-seq), SNP-chip, Protein expression, eQTL/sQTL/pQTL, Presence or absence of endogenous herpesvirus 6, anellovirus load |
| COVID-19: 2,393 + 2,148 cases Healthy controls: 3,289 + 53,269 individuals (Japanese) | Controlled-access (Type I)Unrestricted-access |
| 2022-05-26(v1) | 2026-08-13(v5) | ||
| hum0405 | Research on the identification of cancer stem cells for peidatric and adult malignancies | Expression profiling
Sequencing
Methylation profiling
Histone modification | NGS (Exome, RNA-seq, small RNA-seq, WGS, Amplicon-seq, scRNA-seq/ADT-seq/TCR-seq, CUT&RUN-seq)
Methylation array |
| Pediatric B-cell precursor acute lymphocytic leukemia: 69 cases Pediatric acute myeloid leukemia: 9 cases B-cell precursor acute lymphoblastic leukemia: 16 cases chronic active EBV infection: 65 cases infectious mononucleosis: 6 cases 4 healthy individuals (Japanese) | Controlled-access (Type I) |
| 2023-12-25(v1) | 2026-08-05(v4) | ||
| hum0444 | Research to elucidate pathological conditions of skin diseases caused by genetic alterations by multi-omics analysis | Sequencing
Expression profiling
Methylation profiling | NGS (WGS, Exome, Long-read WGS, Amplicon-seq, RNA-seq)
SNP array
Methylation array |
| 8 porokeratosis patients 3 Nevus spilus-type congenital melanocytic nevus (NS-CMN) patients (Japanese) | Controlled-access (Type I) |
| 2024-04-03(v1) | 2026-08-04(v2) | ||
| hum0197 |
| Elucidation of disease state by multi-layered omics analysis | Metagenome, GWAS, Expression profiling, eQTL, Chromatin structure analysis | Metagenome, SNP-chip, NGS (WGS, RNA-seq, scRNA-seq, snRNA-seq, snATAC-seq), Presence or absence of endogenous herpesvirus 6, anellovirus load, Proteomics |
| 95 + 103 + 227 + 30 + 141 + 136 + 88 + 5 + 524 individuals BBJ: 180,215 individuals UK biobank: 377,583 individuals FinnGen: 136,000 + 224,352 individuals BACC: 247,173 individuals PRACTICAL: 140,254 individuals Autoimmune pulmonary alveolar proteinosis: 198 cases Control participants: 395 Ulcerative Colitis: 35 cases Crohn's disease: 39 cases Healthy controls: 40 individuals Intracranial germ cell tumors: 133 cases Control participants: 762 COVID-19: 30 + 43 + 15 cases Healthy controls: 31 + 44 + 27 individuals Healthy subjects: 73 individuals Hunner-type interstitial cystitis: 144 cases Type 2 diabetes: 27,642 cases (BBJ) Control participants: 70,242 (BBJ) Type 2 diabetes: 27,642 cases (UK biobank) Control participants: 70,242 (UK biobank) Recurrent pregnancy loss: 1,728 cases Autoimmune diseases: 2,238 cases Control participants: 2,919 HPV-associated oropharyngeal cancer: 32 cases Non-HPV-associated oropharyngeal cancer: 17 cases Control participants: 2 NMOSD: 240 cases Control participants: 50,578 Psoriasis: 204 cases Control participants: 1,231 Japanese males: 161,026 (BBJ, JCTF, TMM, COVC, HERPACC, JPHC) Japanese male asthma: 3 cases Japanese male COVID-19: 4 cases Myasthenia gravis: 1,434 cases Control participants: 42,913 Moyamoya disease: 401 cases Control participants: 47,255 multiple sclerosis (MS): 20 cases MS: 688 cases (Japanese) Control participants: 205,199 MS: 27,572 cases (European) Control participants: 1,436,801 MS: 819 cases (African） Control participants: 155,904 MS: 295 cases (American） Control participants: 45,569 (Japanese, British, Finnish, African, American) | Controlled-access (Type I)Unrestricted-access |
| 2019-11-15(v1) | 2026-07-31(v31) | |
| hum0210 | Comprehensive genomic analysis of hematological malignancies | Sequencing, Expression profiling | NGS (Exome, RNA-seq) |
| 1 patient with concomitant acute myeloid leukemia and mediastinal germ cell tumor 5 patients with adult T-cell leukemia/lymphoma (Japanese) | Controlled-access (Type I) |
| 2020-04-06(v1) | 2026-07-30(v2) | ||
| hum0511 | Identification of Molecular Markers and Elucidation of Molecular Mechanisms in Aging Using Centenarian Samples | Expression profiling | NGS (scRNA-seq、scTCR-seq、scCITE-seq) |
| 28 healthy individuals (Japanese) | Controlled-access (Type I)Unrestricted-access |
| 2026-07-30(v1) | 2026-07-30(v1) | ||
| hum0574 | Construction of a genome analysis database for malignant tumors | Sequencing, Expression profiling | NGS (Exome, RNA-seq) |
| rectal cancer: 2 cases, gastric adenocarcinoma: 4 cases (Japanese) | Controlled-access (Type I) |
| 2026-07-24(v1) | 2026-07-24(v1) | ||
| hum0588 | Development of Disease Models and Cell Transplantation Therapies through the Optimization of Precise Genome Engineering in Human iPS Cells | Expression profiling | NGS (RNA-seq) |
| undifferentiated iPS cells and differentiated cardiomyocytes: 12 samples (Cell-line) | Controlled-access (Type I) |
| 2026-07-19(v1) | 2026-07-19(v1) | ||
| hum0575 | Comprehensive gene expression analysis in renal cell carcinoma | Expression profiling | NGS (RNA-seq) |
| renal cell carcinoma: 201 cases (Japanese) | Controlled-access (Type I) |
| 2026-07-16(v1) | 2026-07-16(v1) | ||
| hum0556 | Research on the biological characteristics of gene expression profiles and biomarkers for diagnosis and treatment in lung cancer | Histone modification profiling | NGS (ChIP-seq) |
| lung cancer: 17 cases (Japanese) | Controlled-access (Type I) |
| 2026-06-23(v1) | 2026-06-23(v1) | ||
| hum0427 | Establishment of cell lines derived from head and neck malignancies Comprehensive genetic analysis and database construction for head and neck malignancies | Sequencing, Histone modification profiling | NGS (Exome, ChIP-seq) |
| external auditory canal squamous cell carcinoma: 1 case temporal bone squamous cell carcinoma: 5 cases (Japanese) | Controlled-access (Type I) |
| 2023-11-02(v1) | 2026-06-16(v2) | ||
| hum0543 | Research on Large-Scale Genomic Structural Abnormalities and Cancer Genome Evolution in Colorectal Cancer | Sequencing | NGS (WGS) |
| colorectal cancer: 62 cases (Japanese) | Controlled-access (Type I) |
| 2026-06-10(v1) | 2026-06-10(v1) | ||
| hum0214 | Integrative understanding of human immune system by functional genomics and development of intervention strategies for the prevention of autoimmune diseases | Expression profiling, eQTL | NGS (RNA-seq, scRNA-seq), eQTL, BCR repertoire analysis, TCR repertoire analysis |
| 10 Immune-mediated diseases: 544 cases 185 normal controls (Japanese) | Controlled-access (Type I)Unrestricted-access |
| 2020-10-09(v1) | 2026-06-09(v10) | ||
| hum0447 | Comprehensive genomic analysis to elucidate the molecular mechanism of initiation and progression of liver cancer, pancreatic cancer, lung cancer, stomach cancer, colorectal cancer, biliary tract cancer, breast cancer, esophageal cancer, uterine cancer, ovarian cancer, bladder cancer, kidney cancer, head and neck cancer, bone and soft tissue sarcoma, and malignant melanoma. | Sequencing | NGS (WGS) |
| colorectal cancer: 138 cases (Japanese) | Controlled-access (Type I) |
| 2026-06-09(v1) | 2026-06-09(v1) | ||
| hum0006 | Genomic and Genetic Analysis of Brain Tumors and Analysis of Their Clinicopathological Significance | Sequencing, expression profiling, methylation profiling | NGS (Exome, RNA-seq, Target Capture, FLeCS-seq, SMART-seq, WGS), Methylation array |
| 6 astrocytomas 16 oligodendrogliomas gliomas (17 cerebellar gliomas, 8 cerebral glioblastomas and 14 thalamic gliomas) 94 gliomas 12 cerebral cavernous malformations 1 vertebral hemangioma 3 orbital cavernous malformations 1 glioma (Japanese) | Controlled-access (Type I) |
| 2014-01-31(v1) | 2026-06-03(v6) | ||
| hum0541 | Personalized Medicine Based on Genomic Data | Genome-wide association study | SNP-chip |
| BBJ 1st cohort: 176,894 individuals (Japanese) | Controlled-access (Type I) |
| 2026-06-02(v1) | 2026-06-02(v1) | ||
| hum0561 | A Prospective Multicenter Study of Exploring Genomic Correlates of Clinical Outcome in Patients with Metastatic Castration-Sensitive Prostate Cancer Receiving Enzalutamide | Sequencing | NGS (Exome) |
| mCSPC: 76 cases (Japanese) | Controlled-access (Type I) |
| 2026-05-26(v1) | 2026-05-26(v1) | ||
| hum0516 | Nucleosome profiling of cell-free DNA enables detection of metastatic breast cancer, focusing on transcriptional dynamics | Sequencing | NGS (Target Capture) |
| breast cancer: 127 cases (Japanese) | Controlled-access (Type I) |
| 2026-05-20(v1) | 2026-05-20(v1) | ||
| hum0580 | Request for cooperation regarding collection and distribution of human specimens and research using clinical information | Sequencing | NGS (WGS) |
| gastric-type cervical adenocarcinoma: 1 case (Japanese) | Controlled-access (Type I) |
| 2026-05-20(v1) | 2026-05-20(v1) | ||
| hum0175 | Development of actionable molecular targets and/or biomarkers for prognostication and patient stratification in gynecological cancer based on whole-exome sequencing and epigenomic analysis | Sequencing | NGS (Exome, Target Capture) |
| 69 endometrial carcinomas 30 endometrial hyperplasia patients 66 oral MPA-treatment cases (Japanese) | Controlled-access (Type I) |
| 2019-10-02(v1) | 2026-05-19(v3) | ||